搜索临床试验以:Zevalin ( Yttrium-90 Ibritumomab Tiuxetan)
总计1207个结果
-
University Hospital, Clermont-FerrandLaboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques未知
-
University Hospital of Ferrara招聘中
-
Cairo University未知扩张纹 | 点阵 CO2 镭射 | 条纹;阿尔比坎特 | 白纹 | Nd-YAG 激光 | 高频皮肤超声波 | 短脉冲 Nd-YAG | 二氧化碳激光 | 掺钕钇铝石榴石激光器埃及
-
Singapore Clinical Research InstituteSingapore General Hospital; Duke-NUS Graduate Medical School终止评估为期 90 天的口服 TS 研究方案对 PSA、IPSS、血红蛋白和血细胞比容的影响,并评估不良和严重不良事件。新加坡
-
AlbionSprim Advanced Life Sciences未知
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)完全的
-
Seoul National University Bundang Hospital完全的
-
University of Turin, Italy完全的机械通气并发症 | COVID-19 呼吸道感染 | 断奶失败 | ARDS,人类 | COVID-19 急性呼吸窘迫综合征 | 呼吸努力相关的觉醒 | 急性缺氧性呼吸衰竭意大利
-
SCRI Development Innovations, LLCBiogen完全的
-
Northwestern UniversityNational Cancer Institute (NCI)完全的
-
M.D. Anderson Cancer CenterGenentech, Inc.; Biogen完全的
-
Medical University of Graz完全的
-
Northwestern University完全的
-
University of SouthamptonNIHR Clinical Research Facility, University Hospital Southampton NHS Foundation Trust; European... 和其他合作者终止
-
Hamilton Health Sciences CorporationInstitute for Clinical Evaluative Sciences; Population Health Research Institute完全的
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; M.D. Anderson Cancer Center; Dana-Farber Cancer Institute; University... 和其他合作者主动,不招人
-
Lee Fisher, PhDNational Institute of Neurological Disorders and Stroke (NINDS)招聘中
-
Sahlgrenska University Hospital, Sweden尚未招聘胰腺癌 | 手术 | 转移 | 免疫抑制
-
National Research Center for Hematology, RussiaNational Research Center for Hematology招聘中
-
Cairo UniversityAmira Hassan Abdelaziz; Soheir Mahmoud El-Kosery完全的
-
University Hospital Southampton NHS Foundation...Royal Free and University College Medical School完全的淋巴瘤 | 骨髓瘤 | 急性白血病 | Chronic Leukaemia英国
-
Fundació Institut de Recerca de l'Hospital de la...Spanish Clinical Research Network - SCReN完全的
-
Boston Scientific Corporation招聘中
-
The University of Texas Health Science Center at...终止